• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cell-based Assays Market by Product, Application & End-user - Global Forecast to 2018 - Product Image

Cell-based Assays Market by Product, Application & End-user - Global Forecast to 2018

  • Published: May 2014
  • Region: Global
  • 254 Pages
  • Markets and Markets
Cell-based assays are rapidly gaining importance in the field of drug discovery, predictive toxicology and basic research. The global market is estimated to be valued at $8,734 million in 2013 and will grow at a CAGR of 11.1% from 2013 to 2018.

FEATURED COMPANIES

  • Cell Signaling Technology
  • Danaher Corporation
  • Discoverx
  • Perkinelmer, Inc.
  • Promega Corporation
  • MORE

'Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018'

The market for cell-based assays is driven by the preference over biochemical assays and animal models and the emergent 3D cell-based assay techniques in cell-based assays.

There has been a substantial rise in the costs to develop a new drug in recent years. This is specially observed when a new compound enters animal testing. The use of animals in experimentation is becoming dearer, due to limitations such as high costs involved in breeding and acquisition of animals, due to the complexity of procedures involved in the in vivo testing, and several other ethical issues and legal issues associated with it. Moreover the traditional biochemical assays also posses many limitations. To counteract these issues there has been a paradigm shift towards the use of cell-based assays.

The consumables formed the largest product segment of the total cell-based assays market in 2013, which includes assay kits and reagents, READ MORE >

1 Introduction
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data From Secondary Sources
1.6.4 Key Data Points From Primary Sources
1.6.5 Assumptions

2 Executive Summary

3 Premium Insights
3.1 Global Cell-Based Assays Market
3.2 Market Dynamics
3.3 Snapshot of the Market
3.4 Consumables & Instruments Market For Cell-Based Assays
3.5 Geographic Analysis
3.6 Application Market
3.7 End User Market

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Significant Advantages of Cell-Based Assays Over Conventional Techniques Provide Ideal Solution For A Range of Research & Commercial Applications
4.2.1.2 Government Funding and Public-Private Partnerships Support Cell-Based Research Activities
4.2.1.3 Drug Discovery, Major Driver For Cell-Based Assays Market
4.2.1.4 Implementation of Hts and Automation Techniques Accelerates the Drug Discovery Process
4.2.2 Restraints
4.2.2.1 Shortage of Skilled Experts & High Instrument Costs Have A Negative Impact
4.2.2.2 Skepticism About Long-Term Benefits of Reporter Assay Kits May Affect their Adoption
4.2.2.3 Intellectual Property Rights Issues Restrict Innovations in the Market
4.2.3 Opportunities
4.2.3.1 Asian Market Presents High-Growth Opportunities
4.2.3.2 Need to De-Risk Early-Phase Drug Discovery Reinforces Cell-Based toxicity Screening
4.2.3.3 Developments in High-Content Screening and Software to Transform Cell-Based Screening
4.2.4 Trends
4.2.4.1 Use of Stem Cells & 3d Culture Defines the Future of the Market
4.2.4.2 Assay Development and Assay Screening Services Are the Most Prominent Trend
4.2.4.3 Label-Free Technologies Are Set to Transform the Market
4.3 Burning Issues & Challenges
4.3.1 Consistent Supply of Cells Creates A Bottleneck
4.3.2 New Technologies Call For Assay Optimization
4.4 Winning Imperatives
4.4.1 Assay Multiplexing
4.4.2 Assay Miniaturization & Microfluidics
4.5 Porter's Five Forces Analysis
4.5.1 Threat From New Entrants
4.5.2 Threat From Substitutes
4.5.3 Competitors Rivalry
4.5.4 Bargaining Power of Suppliers
4.5.5 Bargaining Power of Buyers
4.6 Market Share Analysis

5 Cell-Based Assays Market, By Product
5.1 Introduction
5.2 Consumables
5.2.1 Reagents & Assay Kits
5.2.1.1 Cell Growth Assays
5.2.1.2 Cell Death Assays
5.2.1.3 Second Messenger Assays
5.2.1.4 Reporter Gene Assays
5.2.1.5 Other Assays
5.2.2 Microplates
5.2.3 Cell Lines
5.2.3.1 Immortalized Cell Lines
5.2.3.2 Primary Cell Lines
5.2.3.3 Stem Cell Lines
5.2.4 Other Consumables
5.3 Instruments
5.3.1 Detection & Screening Instruments
5.3.1.1 Microplate Readers
5.3.1.2 Flow Cytometers
5.3.1.3 Fluorescent Microscopes
5.3.1.4 High Content Screening Instruments
5.3.1.5 Label-Free Detection Instruments
5.3.1.6 Other Detection and Screening Instruments
5.3.2 Automation & High Throughput Screening Instruments
5.4 Software
5.5 Services

6 Cell-Based Assays Market, By Application
6.1 Introduction
6.2 Basic Research
6.3 Drug Discovery
6.3.1 Target Identification and Validation
6.3.2 Lead Identification & Optimization
6.4 Absorption, Distribution, Metabolism & Excretion (Adme) Studies
6.5 Predictive Toxicology
6.6 Other Applications

7 Cell-Based Assays Market, By End User
7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.3 Academic & Government Institutions
7.4 Contract Research Organizations (CRO)
7.5 Other End Users (Hospitals/Clinical Labs, Food/ Agriculture Industries & Environmental Labs)

8 Cell-Based Assays, By Geography
8.1 Introduction
8.2 North America
8.2.1 Emphasis on Technological Advancements Drives the U.S. Market
8.2.2 Research Networks in Canada to Boost the Market
8.3 Europe
8.3.1 Decline in Venture Capitalist Investments in Early Drug Discovery Shifts the Burden to Public Funding
8.3.2 Public-Private Partnerships to Accelerate Drug Discovery Process in European Union
8.4 Asia
8.4.1 Stem Cell Research in Japan
8.4.2 Drug Discovery Outsourcing Fuels the Market Growth in China and India
8.5 ROW

9 Competitive Landscape
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Collaborations & Partnerships
9.4 Acquisitions
9.5 Others

10 Company Profiles
10.1 Becton, Dickinson and Company
10.2 Cell Signaling Technology
10.3 Cisbio Bioassays (Argos Soditic)
10.4 Danaher Corporation
10.5 Discoverx
10.6 EMD Millipore (A Subsidiary of Merck Kgaa)
10.7 Ge Healthcare (Subsidiary of General Electric Company)
10.8 Life Technologies (Thermo Fisher Scientific)
10.9 Perkinelmer, Inc.
10.10 Promega Corporation

*Details on Business Overview, Financials, Product & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (88)

Table 1 Global Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 2 Global Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 3 Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 4 Global Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 5 Consumables Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 6 Global Reagents & Assay Kits Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 7 Reagents & Assay Kits Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 8 Cell Growth Assays Market, By Geography, 2011–2018 ($Million)
Table 9 Cell Death Assays Market, By Geography, 2011–2018 ($Million)
Table 10 Second Messenger Assays Market, By Geography, 2011–2018 ($Million)
Table 11 Reporter Gene Assays Market, By Geography, 2011–2018 ($Million)
Table 12 Other Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 13 Microplates Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 14 Global Cell Lines Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 15 Cell Lines Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 16 Other Consumables Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 17 Global Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 18 Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 19 Global Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 20 Detection & Screening Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 21 Microplate Readers Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 22 Flow Cytometers Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 23 Fluorescent Microscopes Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 24 High Content Screening Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 25 Label-Free Detection Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 26 Other Detection & Screening Instruments For Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 27 Automation & Hts Instruments Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 28 Software Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 29 Services Market For Cell-Based Assays, By Geography, 2011–2018 ($Million)
Table 30 Global Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 31 Cell-Based Assays Market For Basic Research, By Geography, 2011–2018 ($Million)
Table 32 Cell-Based Assays Market For Drug Discovery, By Geography, 2011–2018 ($Million)
Table 33 Global Cell-Based Assays Market For Drug Discovery, By Type, 2011–2018 ($Million)
Table 34 Cell-Based Assays Market For Target Identification & Validation, By Geography, 2011–2018 ($Million)
Table 35 Cell-Based Assays Market For Lead Identification & Optimization, By Geography, 2011–2018 ($Million)
Table 36 Cell-Based Assays Market For Adme Studies, By Geography, 2011–2018 ($Million)
Table 37 Cell-Based Assays Market For Predictive Toxicology, By Geography, 2011–2018 ($Million)
Table 38 Cell-Based Assays Market For Other Applications, By Geography, 2011–2018 ($Million)
Table 39 Global Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 40 Cell-Based Assays Market For Pharmaceutical & Biotechnology Companies, By Geography, 2011–2018 ($Million)
Table 41 Cell-Based Assays Market For Academic & Government Institutions, By Geography, 2011–2018 ($Million)
Table 42 Cell-Based Assays Market For Contract Research Organizations, By Geography, 2011–2018 ($Million)
Table 43 Cell-Based Assays Market For Other End Users, By Geography, 2011–2018 ($Million)
Table 44 Global Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Table 45 North America: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 46 North America: Consumables Market For Cell-Based Assays, By Product, 2011-2018 ($Million)
Table 47 North America: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 48 North America: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 49 North America: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 50 North America: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 51 North America: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 52 North America: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 53 Europe: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 54 Europe: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 55 Europe: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 56 Europe: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 57 Europe: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 58 Europe: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 59 Europe: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 60 Europe: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 61 Asia: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 62 Asia: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 63 Asia: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 64 Asia: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 65 Asia: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 66 Asia: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 67 Asia: Drug Discovery Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 68 Asia: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 69 ROW: Cell-Based Assays Market, By Product, 2011–2018 ($Million)
Table 70 ROW: Consumables Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 71 ROW: Assay Kits & Reagents Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 72 ROW: Instruments Market For Cell-Based Assays, By Type, 2011–2018 ($Million)
Table 73 ROW: Detection & Screening Instruments Market For Cell-Based Assays, By Product, 2011–2018 ($Million)
Table 74 ROW: Cell-Based Assays Market, By Application, 2011–2018 ($Million)
Table 75 ROW: Cell-Based Assays Market, By Type, 2011–2018 ($Million)
Table 76 ROW: Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Table 77 New Product Launches, 2012–2014
Table 78 Agreements, Partnerships & Collaborations, 2011–2013
Table 79 Acquistions, 2011–2014
Table 80 Other Developments, 2012–2013
Table 81 Becton, Dickinson and Company, By Segment, 2011–2013 ($Million)
Table 82 Danaher Corporation: Total Revenue, By Segment, 2011–2013 ($Million)
Table 83 Merck Kgaa: Total Revenue, 2011–2013 ($Million)
Table 84 General Electric: Total Revenue, By Segment, 2011–2013 ($Million)
Table 85 Life Technologies: Total Revenue, 2010–2012 ($Million)
Table 86 Life Technologies: Total Revenue, By Segment, 2010–2012 ($Million)
Table 87 Life Technologies: Total Revenue, By Geography, 2010–2012 ($Million)
Table 88 Perkinelmer: Total Revenue, By Segment, 2011–2013 ($Million)

List of Figures (20)

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology & Triangulation
Figure 3 Data Triangulation Methodology
Figure 4 Global Cell-Based Assays Market, By Application, 2013 & 2018
Figure 5 Cell-Based Assays Market, By Geography, 2011–2018 ($Million)
Figure 6 Global Cell-Based Assays Market, 2013 ($Million)
Figure 7 Global Cell-Based Assays Market Dynamics
Figure 8 Global Cell-Based Assays Market Snapshot, 2013 ($Million)
Figure 9 Consumables & Instruments Market For Cell-Based Assays, 2013 ($Million)
Figure 10 Cell-Based Assays Market, Geographic Analysis, By Product, 2013 ($Million)
Figure 11 Opportunity Matrix: Global Cell-Based Assays Market By Application, 2013
Figure 12 Global Cell-Based Assays Market, By End User, 2013 Vs 2018 ($Million)
Figure 13 Cell-Based Assays Market: Porter's Five Forces Analysis
Figure 14 Cell-Based Assays, Revenue Market Share Analysis, By Key Players, 2013
Figure 15 Global Cell-Based Assays Market, By Product, 2013 ($Million)
Figure 16 Global Cell-Based Assays Market, By Application, 2013 ($Million)
Figure 17 Cell-Based Assay Applications in Drug Discovery Stages
Figure 18 Global Cell-Based Assays Market, By End User, 2011–2018 ($Million)
Figure 19 Cell-Based Assays Product Lifecycle, By Geography
Figure 20 Key Growth Strategies, Cell-Based Assays Market, 2011–2014

Cell-based assays offer a sensitive and reliable technology that facilitates live cell studies for various research-based and commercial applications. These assays are emerging as a preferred tool when compared to other competing methods such as animal tests and biochemical assays. Cell based assays are more cost and time effective and have higher throughput when compared with conventional animal tests. Also, they produce accurate results and present wider range of applications than the biochemical assays. These are the major factors driving the growth of market.

The global cell-based assays market is segmented on the basis of products, applications, and end users. The products market is further subdivided into consumables (including reagents and assay kits, microplates and cell lines), instruments (detection and screening instruments such as microplate readers, flow cytometers, label-free detection instruments fluorescence microscopes, high content screening instruments and automation and high throughput screening instruments), software and cell based assay development services. Major types of cell based assays captured in the report include cell growth assays, cell death assays, second messenger assays and reporter gene assays.

Based on applications, the cell based assays market is categorized into basic research, drug discovery, ADME, predictive toxicology and other applications. Drug discovery represents the largest share of amongst these applications. With rapid developments in fields such as cell biology, genomics, proteomics and bioinformatics, the number of potential drug candidates has risen significantly, and so have the drug discovery studies.

Based on end users, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs).

Based on geography, this market is further segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share of cell based assay in 2013, followed by Europe and Asia. However, the Asian market is expected to witness a healthy growth over the next five years due to the mushrooming CRO market in this region.

Government initiatives and public-private partnerships along with drying drug pipeline in pharmaceutical industry have led to increase in drug discovery activities; which is stimulating the market growth. Presently, the market is all set to witness trends such as label free detection, drug discovery outsourcing, 3D culture and stem cells. However, the major hindrances to the growth of the market are high-cost associated with detection technologies and intellectual property issues for assay kits.

The key players in the cell-based assays market include BD Biosciences (U.S.), Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K), Life Technologies Corporation (U.S.), PerkinElmer (U.S.), Corporation (U.S.) and Promega (U.S.).

- Becton, Dickinson and Company
- Cell Signaling Technology
- Cisbio Bioassays (Argos Soditic)
- Danaher Corporation
- Discoverx
- EMD Millipore (A Subsidiary of Merck Kgaa)
- Ge Healthcare (Subsidiary of General Electric Company)
- Life Technologies (Thermo Fisher Scientific)
- Perkinelmer, Inc.
- Promega Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos